These pathways included the adenosine monophosphate-activated protein kinase (AMPK) signaling pathway, non-alcoholic fatty liver disease, the JAK-STAT signaling pathway, the biosynthesis of unsaturated fatty acids, the circadian rhythm, and apoptosis-multiple species (Figure 4I). This evidence concerns the gene SOAT1 and metabolic dysfunction-associated steatotic liver disease.